Skip to main content

Table 3 Genotypes and alleles frequency of the IL-13 and IL-19 polymorphisms in preeclampsia and control groups

From: Highlighting allelic variations at the interleukin-19 locus in term of preeclampsia predisposing factors and access to an accurate diagnostic/screening option

Genotypes and alleles

Control group

Patient group

P-value

n (%)

n (%)

rs20541 (G/A)

 GG

4(2.7)

1(0.7)

0.4

 AA

3(2)

3(2)

 GA

143(95.3)

146(97.3)

 G

149(49.7)

152(50.7)

0.8

 A

151(50.3)

148(49.3)

rs56035208 (G/C)

 CC

146(97.3)

143(95.3)

0.6

 GG

2(1.3)

4(2.7)

 CG

2(1.3)

3(2)

 C

6(2)

11(3.7)

0.2

 G

294(98)

289(96.3)

rs1028181 (T/C)

 CC

20(13.33)

23(15.33)

0.001

 CT

31(20.66)

59(39.33)

 TT

99 (66)

68(45.33)

 C

71(23.66)

105(35)

0.002

 T

229(76.33)

195(65)

rs2243191(T/C)

 CC

94(62.67)

102(68)

0.032

 CT

36(24)

41(27.33)

 TT

20(13.33)

7(4.67)

 C

224(74.67)

245(81.67)

0.042

 T

76(25.33)

55(18.33)

  1. Data presented as n (%). Significance level of values is 0.05. P-values were calculated with chi-square-test.